Clinical trial / 2021
A 300-mg dose of caffeine did not significantly alter tinnitus-related discomfort or psychoacoustic and electroacoustic measures in chronic tinnitus patients.
Eighty patients with chronic tinnitus followed a 24-hour caffeine-restricted diet and were randomized to receive either a 300-mg caffeine capsule or a placebo (cornstarch). Assessments were performed at baseline and after capsule ingestion using questionnaires (THI, VAS, POMS) and audiometric and otoacoustic evaluations (TEOAE, DPOAE). A significant change in mood (POMS) occurred after caffeine consumption, while THI and VAS scores improved at the second timepoint in both groups. Differences in some audiometry frequencies and otoacoustic measures between baseline and follow-up occurred in both groups but were not clinically relevant, showing that 300 mg of caffeine did not significantly alter tinnitus-related discomfort.
- Study type
- Randomized triple-blind placebo-controlled clinical trial
- Who was studied
- 80 patients with chronic tinnitus
- What was measured
- Tinnitus questionnaires (THI, VAS, POMS) and audiometric/otoacoustic examinations
THE PAPER
The effect of caffeine on tinnitus: Randomized triple-blind placebo-controlled clinical trial.
Ledesma ALL, Leite Rodrigues D, Monteiro de Castro Silva I, Oliveira CA, Bahmad F. PLoS One, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.